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combined with interstitial brachytherapy (clinical cases of 
breast cancer recurrence, recurrent melanoma, etc.). 
Contemporary sophisticated CT-based interstitial 
brachytherapy is based on multi-catheter implants piercing 
the tumor or its bed. The same set of elastic tubes can be 
successfully used for hyperthermia treatment. In this 
approach tiny microwave antennas along with thermometers 
(for temperature measurement and adjustments) are inserted 
into the treated volume via brachytherapy applicators. A set 
of CT scans used for treatment planning delivers strict 
geometrical information about 3D orientation of applicators 
within the CTV and enables the physician to plan the best 
pattern of antennas and thermometers to safely heat the 
target volume just before/after irradiation. Such an example 
of reproducible combination of interstitial BT with interstitial 
and superficial HT supported by CT-based treatment planning 
will be presented. 
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There are mainly four challenges in photon radiotherapy.  
1. Proximity to  critical organs
2. Tumor motion
3. Large tumor volume
4. Radio-resistance
 We have developed and used fiducial markers, four-
dimensional radiotherapy (4DRT) planning concept, and real-
time tumor-tracking radiotherapy (RTRT) system since 1999 
to overcome the first and second problem (Shirato, H. et al. 
Lancet 1999).  It was effective to treat small  tumors such as 
lung, liver, and prostate cancers effectively with the 
accuracy of ± 2 mm even with complex internal organ motion 
(Seppenwoolde, Y. et al. IJROBP 2002).  
We have development a new radiotherapy system with 
Hitachi co ltd  to cure large, moving tumors situated near 
critical organs. It is image-guided spot-scanning proton beam 
therapy system with real-time tumor-tracking system. Cone-
beam CT scan is availabe for precise set-up. Two sets of 
fluoroscope are mounted in the gantry, used for real-time 
tracking of fiducial marker near the tumor, and the proton 
beam is gated to treat large tumors with the accuracy of ± 2 
mm.  The system was approved by Japanese government in 
February 2014 and commercially available as PROBEAT-RT 
(Hitachi, co. ltd., Japan) .  We have been able to successfully 
reduce the size of the system, to make it small enough to be 
installed in the premises of hospitals, by dedicating to the 
spot-scanning Irradiation Technique.  Initial experience of 
this system will be presented.  
Clinical trial has been started since March 2014 for those 
patients who have gain in dose distribution comparing to 
photon therapy.  Acute adverse effects were evaluated and 
shown to be minimal in the initial 6 months. 
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(National Institute of Radiological Sciences) using HIMAC 
(Heavy-Ion Medical Accelerator in Chiba), which was the 
world’s first heavy ion accelerator complex dedicated to 
medical use in a hospital environment. As of February 2014, a 
total of 8,931 patients were treated with carbon ion 
radiotherapy using HIMAC. The results have shown that 
carbon ion radiotherapy has the ability to provide a sufficient 
dose to the tumor without unacceptable morbidity in the 
surrounding normal tissues. Tumors that appear to respond 
favorably to carbon ions include locally advanced tumors and 
those with histologically non-squamous cell type of tumors 
such as adenocarcinoma, adenoid cystic carcinoma, 
malignant melanoma, hepatoma, and bone and soft tissue 
sarcomas. By using biological and physical properties of the 
high-LET carbon ion beams, the efficacy of treatment 
regimen with small fractions in shorter treatment course has 
been also confirmed for almost all type of tumors in our 
carbon ion radiotherapy experience. More than 10,000 
patients treated with carbon therapy worldwide, more than 
80% were treated at NIRS and other facilities in Japan. The 
current facilities and devices may be termed as first-
generation equipment. Making existing equipment smaller 
and less expensive is only the first step. It is be far from 
satisfactory for next-generation facility. One new technique 
that deserves attention as the next generation system is the 
spot scanning beam delivery and the compact 
superconducting magnet mounted rotating gantry. Spot 
scanning beam delivery is designed to treat the complex-
shaped lesions that are difficult targets for the by current 
techniques. Use of the rotating gantry will minimize the time 
for patient positioning and improve patient comfort. Owing 
to simplified treatment set-up procedures and reduced 
treatment time, more patients with poor performance status 
will be eligible for this therapy. We anticipate that the 
introduction of these innovations will not only improve the 
therapeutic outcome but also increase patient throughput. 
The new system will also eliminate the need for making 
compensation filters as well as patient-specific collimators. 
NIRS has finished the construction of the new facility's 
building and the installation of the beam delivery system for 
the pencil beam scanning. A clinical research using the pencil 
beam scanning was in operation with the original fully 
automated patient positioning system since May 2011. We 
could treat a total of almost 1000 patients in the FS year of 
2013 by the broad beam delivery and the pencil beam 
scanning. Good performance of this new carbon pencil beam 
delivery system has been confirmed at NIRS. Regarding the 
compact superconducting magnet mounted rotating gantry, 
the magnets for the gantry were already made and have been 
testing at NIRS successfully. The NIRS novel gantry system 
will be expected to be in operation in early 2016. 
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